(Q40348474)

English

A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts

scientific article published on 21 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

7

object named as

Serdar E Bulun

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Santanu Deb

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Jianfeng Zhou

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sanober A Amin

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Ayse Gonca Imir

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Mehmet Bertan Yilmaz

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhihong Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

21 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

281

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2585-2597

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Local endocrine effects of aromatase inhibitors within the breast

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

An integrated view of aromatase and its inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Regulation of estrogen concentrations in human breast tissues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Estrogen Excess Associated with Novel Gain-of-Function Mutations Affecting the Aromatase Gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Spreading of transcriptional repressor SIR3 from telomeric heterochromatin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Characterization of a novel silencer element in the human aromatase gene PII promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Characterization of a silencer element in the human aromatase gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Transcriptional regulation by cyclic AMP.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Regulation of activating transcription factor-2 in early stage of the adipocyte differentiation program

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Interaction and functional collaboration of p300 and C/EBPbeta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Ras/MAP kinase pathways are involved in Ras specific apoptosis induced by sodium butyrate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

A protein phosphatase is involved in the inhibition of histone deacetylation by sodium butyrate

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Butyrate-induced differentiation of colon cancer cells is PKC and JNK dependent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M508498200

21 January 2018

Identifiers

10.1074/JBC.M508498200

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40348474&oldid=1895818317"